SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jerry Olson who wrote (14560)9/11/1998 5:38:00 PM
From: Judy  Read Replies (2) | Respond to of 120523
 
OJ, read that article very carefully. Arava is an RA drug made by HOE ... competitor to IMNX's Enbrel. That is why IMNX was under pressure today before recovering when the market realized that Enbrel is far superior.



To: Jerry Olson who wrote (14560)9/11/1998 9:18:00 PM
From: Dave Shares  Read Replies (1) | Respond to of 120523
 
(OT)

Jerry,

When it comes to stock trading, I'm a rookie, as I make too many damn mistakes.

When it comes to politics...well, let's just say that I have about 20 years of experience, including having held public office, so there I may claim to know a bit.

David


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News